CACNA1C and Timothy syndrome: Roscovitine, both an atypical LTCC blocker and a cyclin-dependent kinase inhibitor, which can enhance the VDI of CaV1.2, restored the electrical and calcium signaling properties of cardiomyocyte from TS patients [72–75].